408 related articles for article (PubMed ID: 1840243)
1. [Immunogenicity and harmlessness in the newborn of a vaccine (GenHevac B) containing the antigens S and pre-S2].
Tron F; Soulié JC; Goudeau A; Devillier P; Saliou P
Bull Soc Pathol Exot; 1991; 84(5 Pt 5):901-5. PubMed ID: 1840243
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and safety in newborns of a new recombinant hepatitis B vaccine containing the S and pre-S2 antigens.
Soulié JC; Devillier P; Santarelli J; Goudeau A; Vermeulen P; Guellier M; Saliou P; Hillion AM; Tron F; Huchet J
Vaccine; 1991 Aug; 9(8):545-8. PubMed ID: 1837646
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B immunization in high risk neonates born from HBsAg and HBeAg positive mothers: comparison of standard and low dose regimens.
Pongpipat D; Suvatte V; Assateerawatts A
Asian Pac J Allergy Immunol; 1988 Dec; 6(2):107-10. PubMed ID: 2975491
[TBL] [Abstract][Full Text] [Related]
4. Anti-HBs levels in infants of hepatitis B carrier mothers after delayed active immunization with recombinant vaccine concomitant with DTP-polio vaccine: is there need for a second dose of HBIg? Dutch Study Group on Prevention of Neonatal Hepatitis B.
Grosheide PM; del Canho R; Voogd M; Heijtink RA; Schalm SW
Vaccine; 1994 Sep; 12(12):1059-63. PubMed ID: 7998413
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B immunization in high risk neonates born from HBsAg positive mothers: comparison between plasma derived and recombinant DNA vaccine.
Pongpipat D; Suvatte V; Assateerawatts A
Asian Pac J Allergy Immunol; 1989 Jun; 7(1):37-40. PubMed ID: 2526633
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B vaccination in diabetic patients. Randomized trial comparing recombinant vaccines containing and not containing pre-S2 antigen.
Douvin C; Simon D; Charles MA; Deforges L; Bierling P; Lehner V; Budkowska A; Dhumeaux D
Diabetes Care; 1997 Feb; 20(2):148-51. PubMed ID: 9118762
[TBL] [Abstract][Full Text] [Related]
7. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
Gunn TR; Bosley A; Woodfield DG
N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of antigen dosage on the hepatitis B vaccine response in infants born to hepatitis B-uninfected and hepatitis B-infected mothers.
Kang G; Ma F; Chen H; Yang Y; Guo S; Wang Z; Liang X; Li L; Cui F; Zhang L
Vaccine; 2015 Aug; 33(33):4093-9. PubMed ID: 26144895
[TBL] [Abstract][Full Text] [Related]
9. Comparative immunogenicity in children of mammalian cell-derived recombinant hepatitis B vaccine and plasma-derived hepatitis B vaccine.
Coursaget P; Bringer L; Sarr G; Bourdil C; Fritzell B; Blondeau C; Yvonnet B; Chiron JP; Jeannée E; Guindo S
Vaccine; 1992; 10(6):379-82. PubMed ID: 1534640
[TBL] [Abstract][Full Text] [Related]
10. Safety and immunogenicity of a novel mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in neonates.
Yerushalmi B; Raz R; Blondheim O; Shumov E; Koren R; Dagan R
Pediatr Infect Dis J; 1997 Jun; 16(6):587-92. PubMed ID: 9194109
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and efficacy of a recombinant DNA hepatitis B vaccine, GenHevac B Pasteur in high risk neonates, school children and healthy adults.
Assateerawatt A; Tanphaichitr VS; Suvatte V; Yodthong S
Asian Pac J Allergy Immunol; 1993 Jun; 11(1):85-91. PubMed ID: 8216564
[TBL] [Abstract][Full Text] [Related]
12. Anti-pre-S2 antibodies in natural hepatitis B virus infection and after immunization.
Coursaget P; Adamowicz P; Bourdil C; Yvonnet B; Buisson Y; Barrès JL; Saliou P; Chiron JP; Mar ID
Vaccine; 1988 Aug; 6(4):357-61. PubMed ID: 2973189
[TBL] [Abstract][Full Text] [Related]
13. [Combined immunoprophylaxis induces changes in anti-hepatitis B surface protein titer in infants born to mothers with positivity for hepatitis B surface antigen].
Wang J; Feng YL; Liu MH; Bai Y; Feng DH; Yuan NX; Du DQ; Feng WH; Liu HL; Yang Y; Liu JF; He YL; Song HX; Liu Y; Zhao YR; Chen TY
Zhonghua Gan Zang Bing Za Zhi; 2013 Aug; 21(8):580-3. PubMed ID: 24119736
[TBL] [Abstract][Full Text] [Related]
14. An efficacy trial of a mammalian cell-derived recombinant DNA hepatitis B vaccine in infants born to mothers positive for HBsAg, in Shanghai, China.
Halliday ML; Kang LY; Rankin JG; Coates RA; Corey PN; Hu ZH; Zhou TK; Yuan GJ; Yao FL
Int J Epidemiol; 1992 Jun; 21(3):564-73. PubMed ID: 1386063
[TBL] [Abstract][Full Text] [Related]
15. The comparison of antibody response to different hepatitis b vaccines with and without pre-S2 antigen in children with cancer.
Emir S; Büyükpamuk M; Akyüz C; Kutluk T; Güler E; Cağlar K
Pediatr Hematol Oncol; 2002 Jun; 19(4):227-33. PubMed ID: 12051588
[TBL] [Abstract][Full Text] [Related]
16. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study.
Zanetti AR; Mariano A; Romanò L; D'Amelio R; Chironna M; Coppola RC; Cuccia M; Mangione R; Marrone F; Negrone FS; Parlato A; Zamparo E; Zotti C; Stroffolini T; Mele A;
Lancet; 2005 Oct 15-21; 366(9494):1379-84. PubMed ID: 16226616
[TBL] [Abstract][Full Text] [Related]
17. The protective efficacy of recombinant hepatitis B vaccine in newborn infants of hepatitis B e antigen-positive-hepatitis B surface antigen carrier mothers.
Lee CY; Huang LM; Chang MH; Hsu CY; Wu SJ; Sung JL; Safary A
Pediatr Infect Dis J; 1991 Apr; 10(4):299-303. PubMed ID: 1829515
[TBL] [Abstract][Full Text] [Related]
18. Comparative safety and immunogenicity of yeast recombinant hepatitis B vaccines containing S and pre-S2 + S antigens.
Miskovsky E; Gershman K; Clements ML; Cupps T; Calandra G; Hesley T; Ioli V; Ellis R; Kniskern P; Miller W
Vaccine; 1991 May; 9(5):346-50. PubMed ID: 1872019
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the immune response of four different dosages of a yeast-recombinant hepatitis B vaccine in Singapore children: a four-year follow-up study.
Goh KT; Tan KL; Kong KH; Oon CJ; Chan SH
Bull World Health Organ; 1992; 70(2):233-9. PubMed ID: 1600584
[TBL] [Abstract][Full Text] [Related]
20. Field evaluation of the efficacy and immunogenicity of recombinant hepatitis B vaccine without HBIG in newborn Vietnamese infants.
Milne A; West DJ; Chinh DV; Moyes CD; Poerschke G
J Med Virol; 2002 Jul; 67(3):327-33. PubMed ID: 12116022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]